Axogen, Inc. Common Stock (AXGN) — Analysis Summary
Axogen, Inc. Common Stock (AXGN) has a market cap of $2.10B with year-over-year revenue growth of +20.2%. Net margin stands at -7.0%. The stock trades at a P/E ratio of -66.7.
Key Takeaways
- Revenue changed +20.2% year-over-year
- Net margin of -7.0%
- P/E ratio of -66.7
Compared to other companies in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector, AXGN posted revenue growth of +20.2% and trades at a P/E of -66.7.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.